Our operational mission is to craft customized strategies that achieve cost-effective trials by 1) simplifying clinical plans, 2) streamlining trial protocols and 3) creating robust regulatory roadmaps for speed to market.
BBCR’s extensive experience in biologics for rare diseases allows us to assist with the development of a targeted strategy to meet your study needs.
Examples of the strategies we utilize to move products to market faster include:
- A cost-effective Clinical Plan that saves time and resources
- Medical Monitoring
- Ad-interim Chief Medical Monitor
- Indications Selection and Prioritization
- Trial Design and Protocol
- Study Remediation and Rescue
- Clinical research consultation for regulatory submissions and meetings
- Program Gap Analyses
We invite you to reach out today to learn more.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.